Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
- About
Translational Development Acquisition Corp. Units (TDACU)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: TDACU (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $0
1 Year Target Price $0
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 0% | Avg. Invested days 10 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  5.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 10.00 - 10.42 | Updated Date 05/1/2025 |
52 Weeks Range 10.00 - 10.42 | Updated Date 05/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 41319452 | Price to Sales(TTM) - |
Enterprise Value 41319452 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 3032762 |
Shares Outstanding - | Shares Floating 3032762 | ||
Percent Insiders - | Percent Institutions 84.31 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Translational Development Acquisition Corp. Units
Company Overview
History and Background
Translational Development Acquisition Corp. was a blank check company (SPAC) formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Units typically consist of one share of common stock and a fraction of a warrant.
Core Business Areas
- SPAC Formation: The company's primary activity was to identify and acquire a target company.
Leadership and Structure
Typically led by a management team experienced in acquisitions and the target industry. Structure involves a board of directors and officers focused on deal sourcing and execution.
Top Products and Market Share
Key Offerings
- Units (Pre-Acquisition): Offered units consisting of common stock and warrants. Market share is not applicable for a SPAC prior to acquisition, as they do not have products or services. Competitors are other SPACs seeking acquisition targets in similar industries.
Market Dynamics
Industry Overview
SPACs operate in the financial market, competing for acquisition targets. The industry is sensitive to market conditions, regulatory changes, and investor sentiment.
Positioning
Positioned as a vehicle for a private company to go public more quickly than through a traditional IPO.
Total Addressable Market (TAM)
The TAM is difficult to quantify as it depends on the size and number of private companies seeking to go public. Translational Development Acquisition Corp.'s positioning was to find an attractive target within its stated focus.
Upturn SWOT Analysis
Strengths
- Experienced management team
- Dedicated capital for acquisition
- Speed to market for target company
Weaknesses
- Time constraints to complete acquisition
- Dependence on finding suitable target
- Dilution for existing shareholders
Opportunities
- Favorable market conditions for acquisitions
- Growing number of private companies seeking public listing
- Potential for high returns if successful acquisition
Threats
- Increased competition from other SPACs
- Unfavorable market conditions
- Regulatory changes
- Failure to find suitable target
Competitors and Market Share
Key Competitors
Competitive Landscape
The competitive landscape consists of other SPACs, each vying for attractive acquisition targets. The advantage depends on industry focus and management expertise.
Growth Trajectory and Initiatives
Historical Growth: Growth is measured by the company's success in identifying and acquiring a target company.
Future Projections: Future growth depends entirely on the acquired company's performance post-merger.
Recent Initiatives: Focused on deal sourcing and due diligence of potential target companies.
Summary
Translational Development Acquisition Corp. was a SPAC seeking an acquisition target. Its success hinged on finding a suitable company and executing a successful merger. The risks included failing to find a target or market headwinds affecting the acquisition process. Ultimately success depended on the performance of the acquired company post-merger.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings
- Financial News Outlets
Disclaimers:
This analysis is based on publicly available information and is not financial advice. The performance of SPACs is highly speculative and depends on various factors.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Translational Development Acquisition Corp. Units
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2024-12-23 | Chairman of the Board & CEO Mr. Michael M. B. Hoffman J.D. | ||
Sector Financial Services | Industry Shell Companies | Full time employees - | |
Full time employees - | |||
Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.